Does Specific Immunotherapy Injection Cause an Increase in Bronchial Reactivity?

References

• O'Byrne P M, Dolovich J, Hargreave F E. Late asthmatic responses.Am Rev Respir Dis 1987; 136:740–751. [CSA]
   PubMed Web of Science ®Google Scholar
• Cartier A, Thomson N C, Frith P A, Roberts R, Hargreave F E. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber.J Allergy Clin Immunol 1982; 70:170–177. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Cirillo I, Tosca M A, Vizzaccaro A. Bronchial hyperreactivity and spirometric impairment in patients with seasonal allergic rhinitis.Respir Med 2004; 98:826–831. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Orhan F, Sekerel B E, Adalioglu G, Pinar M, Tuncer A. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.Ann Allergy Asthma Immun 2004; 92:438–445. [CSA]
   PubMed Web of Science ®Google Scholar
• Vignola A M, Bousquet J. Rhinitis and asthma: a continuum of disease?. Clin Exp Allergy 2001; 31:674–677. [CSA], [CROSSREF]
   Google Scholar
• Wardlaw A J. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm.J Allergy Clin Immunol 1999; 104:917–926. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Denburg J A, Inman M D, Sehmi R, Uno M, O'Byrne P M. Hemopoietic mechanisms in allergic airway inflammation.Int Arch Allergy Immunol 1998; 117:155–159. [CSA], [CROSSREF]
   Google Scholar
• Wang C H, Hsieh W Y, Shih L Y, Lin H C, Liu C Y, Chung K F, Kuo H P. Increased progenitor cell proliferation in the peripheral blood of patients with bronchial asthma: the role of nitric oxide.J Allergy Clin Immunol 1999; 104:803–810. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Bachert C, van Cauwenberge P, Khaltaev N, World Health Organization. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. December 7–10, 1999, Geneva, Switzerland.Allergy 2002; 7:841–855. [CSA]
   Google Scholar
• Ariano R, Kroon A M, Augeri G, Canonica G W, Passalacqua G. Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial.Allergy 1999; 54:313–319. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Polosa R, Li Gotti F, Mangano G, Paolino G, Mastruzzo C, Vancheri C, Lisitano N, Crimi N. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis.Allergy 2004; 59:1224–1228. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moller C, Dreborg S, Ferdousi H A, Halken S, Host A, Jacobsen L, Koivikko A, Koller D Y, Niggemann B, Norberg L A, Urbanek R, Valovirta E, Wahn U. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).J Allergy Clin Immunol 2002; 109:251–256. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, the Joint Council of Allergy, Asthma and Immunology. Practice parameters for allergen immunotherapy.J Allergy Clin Immunol 1996; 98:1001–1011. [CSA]
   Google Scholar
• Position paper: immunotherapy. (EAACI) The European Academy of Allergology and Clinical Immunology.Allergy 1993; 48:7–35. [CSA]
   Google Scholar
• Goodson R L. Good clinical practices: past, present, and future.Qual Assur 1995; 4:60–67. [CSA]
   PubMedGoogle Scholar
• Alvarez M J, Olaguibel J M, Garcia B E, Tabar A I, Urbiola E. Comparison of allergen-induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients.Allergy 2000; 55:531–539. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sekerel B E, Saraclar Y, Tuncer A, Adalioglu G, Cetinkaya F. Standardization of methacholine inhalation challenge.Turk J Pediatr 1997; 39:165–172. [CSA]
   Google Scholar
• Braunstahl G J, Kleinjan A, Overbeek S E, Prins J B, Hoogsteden H C, Fokkens W J. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients.Am J Respir Crit Care Med 2000; 161:2051–2057. [CSA]
   PubMed Web of Science ®Google Scholar
• Braunstahl G J, Fokkens W. Nasal involvement in allergic asthma.Allergy 2003; 58:1235–1243. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Smith T R, Larche M. Investigating T cell activation and tolerance in vivo: peptide challenge in allergic asthmatics.Cytokine 2004; 28:49–54. [CSA], [CROSSREF]
   Google Scholar
• Beasley R, Roche W R, Roberts J A, Holgate S T. Cellular events in the bronchi in mild asthma and after bronchial provocation.Am Rev Respir Dis 1989; 139:806–817. [CSA]
   PubMed Web of Science ®Google Scholar
• Bousquet J, Chanez P, Lacoste J Y, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P. Eosinophilic inflammation in asthma.N Engl J Med 1990; 323:1033–1039. [CSA]
   PubMed Web of Science ®Google Scholar
• Bradley B L, Azzawi M, Jacobson M, Assoufi B, Collins J V, Irani A M, Schwartz L B, Durham S R, Jeffery P K, Kay A B. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness.J Allergy Clin Immunol 1991; 88:661–674. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gavett S H, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4 + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia.Am J Respir Cell Mol Biol 1994; 10:587–593. [CSA]
   PubMed Web of Science ®Google Scholar
• Cohn L, Tepper J S, Bottomly K. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells.J Immunol 1998; 161:3813–3816. [CSA]
   PubMed Web of Science ®Google Scholar
• Huang T J, MacAry P A, Eynott P, Moussavi A, Daniel K C, Askenase P W, Kemeny D M, Chung K F. Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma.J Immunol 2001; 166:207–217. [CSA]
   PubMed Web of Science ®Google Scholar
• Kahlert H, Grage-Griebenow E, Stuwe H T, Cromwell O, Fiebig H. T cell reactivity with allergoids: influence of the type of APC.J Immunol 2000; 165:1807–1815. [CSA]
   PubMedGoogle Scholar
• Linna O, Kokkonen J, Lukin M. A 10-year prognosis for childhood allergic rhinitis.Acta Paediatr 1992; 81:100–102. [CSA]
   PubMed Web of Science ®Google Scholar
• Ramsdale E H, Morris M M, Roberts R S, Hargreave F E. Asymptomatic bronchial hyperresponsiveness in rhinitis.J Allergy Clin Immunol 1985; 75:573–577. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ferdousi H A, Dreborg S. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.Clin Exp Allergy 1997; 27:530–539. [CSA], [CROSSREF]
   Google Scholar
• Madonini E, Briatico-Vangosa G, Pappacoda A, Maccagni G, Cardani A, Saporiti F. Seasonal increase of bronchial reactivity in allergic rhinitis.J Allergy Clin Immunol 1987; 79:358–363. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar